(Date:12/1/2009)... Dec. 1 Expanding its European rea... of Sarasota has appointed Lake Chemicals and Mine...ocated near Birmingham, England. ,, Osprey bre...he agricultural, waste water, and environmental ma...pen drain fields, and clean up industrial and mari...
(Date:12/1/2009)...Vax, Inc. today announced a collaborative research... aimed at evaluating EpiVax’s proprietary Tr... detrimental immune responses to certain drugs. In... EpiVax Tregitope technology will be evaluated for...rapeutics. , (Vocus) Dece...
(Date:12/1/2009)...ON BEACH, California and AMSTERDAM, December 1 /PR...cancer diagnostics, announced today that,Palmetto ...as established,coding guidelines for the company,s...red breast cancer recurrence test, which has been ...ts across the United States can now submit claims ...
(Date:12/1/2009)...EAL, Dec. 1 /PRNewswire-FirstCall/ - BioSpec Globa...CBT), announced today that the company has contrac...anada for the manufacturing of the TOG,S 3000 and ..., "We have seen the disastrous results of food c...kaged salads in the past" said Don Saunders Presid...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2...RIDGEWATER, Mass., Aug. 14 Pressure,BioSciences, ...evenue for the,quarter ended June 30, 2007 was $20...n 2006. Revenue from the sale of PCT products and ...une 30, 2007 as compared to $28,783,for the same p...from PCT,products and services was the result of t...
...GELES, Aug. 14 Response Genetics, Inc.,(Nasdaq: ...econd quarter,ended June 30, 2007. "The second qu...ics,beginning with our successful initial public o...nt and CEO of Response Genetics. "We are very,plea...n announced. During,the quarter these developments...
... COTTAGE, New York, August 15 XTL,Biopharmaceutic...biopharmaceutical company engaged in the acquisiti...ics for the treatment of unmet medical needs,parti...nounced its,financial results for the six months e... had cash, cash equivalents and short-term,bank de...
Other Biology Technology:Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 2Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 3Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 4Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 5Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 6Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 7Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update 8Response Genetics Reports Second Quarter 2007 Financial Results 2Response Genetics Reports Second Quarter 2007 Financial Results 3Response Genetics Reports Second Quarter 2007 Financial Results 4Response Genetics Reports Second Quarter 2007 Financial Results 5Response Genetics Reports Second Quarter 2007 Financial Results 6Response Genetics Reports Second Quarter 2007 Financial Results 7Response Genetics Reports Second Quarter 2007 Financial Results 8XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 2XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 3XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 4XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 5XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 6XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 7XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 8XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 9XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 10XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 11XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 12XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 13XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 14.... Corp. announced,today the receipt of purchase or...of 10,576 M9 pistols (5,969 for the Army, 4,607 fo...st a multi-year contract between Beretta,U.S.A. an...ing agent of the,M9 pistol for all branches of the...given the opportunity to serve the U.S.,Armed Forc...
...ently in Use, Including Large Scale, Election En...ons to be Demonstrate...c. (OTC Bulletin Board: BKYI), a leader in finger-... safety, announced today that the company,is showc...applications at,the 2007 Biometric Technology Expo...
...Dale Meyerrose,Chief Information Officer, Office o...the plenary session and Greg Garcia, Assistant Sec...epartment of Homeland Security, has,been invited t...he keynote,speaker. About the Conference: A comm...ollaborated to,create this year,s conference on Oc...
Other Biology News:U.S. Army and Navy Purchase Over 10,000 New Beretta M9 Pistols 2BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo 2BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo 3...ables you to insert a transposable element of your...nsposition. It uses TnsABC* Transposase to insert ...get. Target DNA may be a plasmid, cosmid, BAC or p...ests (6-8). If the insertion site is within a tran...
...pidly and reliably amplify unknown genomic DNA us...hassle-free, ready-to use components, at an extrao...ents are provided in each kit. The Locator Kit can...ctions, bi-directional sequence extension of seque...
...s one of the several main MAP kinase groups Firefl... for studying gene regulation and function. Lucife...in comparison to the standard chloramphenicol acet...lyzes the oxidative carboxylation of luciferin, a ...
Treated Tissue Culture 245 mm x 245 mm Dish, 4/pk from StemCell Technologies, Inc.
Biology Products: